Focus on Psoriasis: A Report from the 2022 IPC Think Tank – Miami
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was
Tuesday, January 24, 2023
Resource Category: Systemic Treatments
Focus on Psoriasis: A Report from the European Academy of Dermatology and Venereology 31st Annual Congress (EADV)
Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The following congress report
Monday, November 7, 2022
Focus on Psoriasis: A Report from the 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN)
Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The following congress report
Friday, August 26, 2022
Real-world Evidence of Systemic Psoriasis Therapies – Part II: Drug Survival Studies and Hazard Ratios
Dr. Egeberg discusses the differences between real-world data and randomized control trials. As well as the benefits of reviewing both
Sunday, April 17, 2022
Real-world Evidence of Systemic Psoriasis Therapies – Part I: Clinical Trials and Observational Studies
Dr. Egeberg discusses the differences between real-world data and randomized control trials. As well as the benefits of reviewing both
Sunday, April 17, 2022
Innovations in Systemic Treatments for Psoriasis
Dr. Blauvelt provides an update on systemic treatments and how they may improve patient outcomes. He also gives a preview
Thursday, March 24, 2022
The Psoriasis Pipeline: Upcoming New Systemic Drugs
The Psoriasis Pipeline: Upcoming New Systemic Drugs Andrew Blauvelt, MD, MBA | United States 2021
Thursday, January 14, 2021
Safety of Systemic Agents for the Treatment of Pediatric Psoriasis
Safety of Systemic Agents for the Treatment of Pediatric Psoriasis Download PDF
Wednesday, September 13, 2017
